Overexpression of PARP is an independent prognostic marker for poor survival in Middle Eastern breast cancer and its inhibition can be enhanced with embelin co-treatment.

Name: Overexpression of PARP is an independent prognostic marker for poor survival in Middle Eastern breast cancer and its inhibition can be enhanced with embelin co-treatment.
Author: Siraj, Abdul Khalid

Overexpression of PARP is an independent prognostic marker for poor survival in Middle Eastern breast cancer and its inhibition can be enhanced with embelin co-treatment. — المؤلف: Siraj, Abdul Khalid — Oncotarget Dec 2018

المؤلف: Siraj, Abdul Khalid
النشر: Oncotarget Dec 2018
الوصف: 37319-37332 p.